Literature DB >> 20733513

Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis.

Jane K Jaffe1, Susmita Paladugu, John P Gaughan, Henry P Parkman.   

Abstract

AIM: Nausea is a common symptom of gastroparesis (GP). The study is to determine the manifestations and impact of nausea in GP and to determine if there are any differences in diabetic (DG) and idiopathic gastroparesis (IG).
METHODS: The patients referred for GP symptoms underwent gastric emptying scintigraphy and completed the Patient Assessment of Gastrointestinal Disorders-Symptom Severity Index (PAGI-SYM), Patient Assessment of Upper Gastrointestinal Disorders-Quality of Life (PAGI-QOL), SF-36v2 Health-Related Quality-of-Life survey, and the Nausea Profile (NP).
RESULTS: Fifty-nine GP patients (20 diabetic, 39 idiopathic; 52 female; mean age 43 y) with delayed gastric emptying were enrolled. Nausea was an important symptom in these patients as assessed by PAGI-SYM (2.3±0.2) and it correlated with worse quality of life by PAGI-QOL (r=-0.299; P=0.021). The nausea and vomiting scores were similar in DG and IG, but DG had more severe retching (2.6±0.3 vs. 1.4±0.3; P=0.02) and more episodes of vomiting per week (4.4±1.4 vs. 3.5±1.3; P=0.037) compared with IG. Using the NP, total nausea scores in DG (61±3) were found to be greater than IG (49 (3; P=0.03) with somatic distress scores (60±5 vs. 44±4; P=0.03), and the gastrointestinal (GI) distress scores (84±4 vs. 73±4; P=0.05) were found to be greater in DG than IG. Although DG had slower gastric emptying than IG, there was no significant correlation between the NP scores and the degree of gastric retention on gastric emptying scintigraphy.
CONCLUSIONS: Nausea and vomiting symptoms correlate with worse quality of life in GP patients. The DG patients experience greater nausea and increased somatic distress than IG. The differential perception of nausea in DG versus IG might be because of distinct pathophysiologic mechanisms.

Entities:  

Mesh:

Year:  2011        PMID: 20733513     DOI: 10.1097/MCG.0b013e3181eeb5e9

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  14 in total

1.  Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.

Authors:  H P Parkman; E K Hallinan; W L Hasler; G Farrugia; K L Koch; J Calles; W J Snape; T L Abell; I Sarosiek; R W McCallum; L Nguyen; P J Pasricha; J Clarke; L Miriel; L Lee; J Tonascia; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2016-06-27       Impact factor: 3.598

2.  Granisetron transdermal system improves refractory nausea and vomiting in gastroparesis.

Authors:  Kellie Simmons; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2014-03-11       Impact factor: 3.199

3.  Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013.

Authors:  William Hirsch; Judy Nee; Sarah Ballou; Travis Petersen; Daniel Friedlander; Ha-Neul Lee; Vivian Cheng; Anthony Lembo
Journal:  J Clin Gastroenterol       Date:  2019-02       Impact factor: 3.062

4.  Exploring Symptom Severity, Illness Perceptions, Coping Styles, and Well-Being in Gastroparesis Patients Using the Common Sense Model.

Authors:  Sally Woodhouse; Geoff Hebbard; Simon R Knowles
Journal:  Dig Dis Sci       Date:  2018-02-22       Impact factor: 3.199

5.  From ischochymia to gastroparesis: proposed mechanisms and preferred management of dyspepsia over the centuries.

Authors:  Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2014-04-09       Impact factor: 3.199

6.  Similarities and differences between diabetic and idiopathic gastroparesis.

Authors:  Henry P Parkman; Katherine Yates; William L Hasler; Linda Nguyen; Pankaj J Pasricha; William J Snape; Gianrico Farrugia; Kenneth L Koch; Jorge Calles; Thomas L Abell; Richard W McCallum; Linda Lee; Aynur Unalp-Arida; James Tonascia; Frank Hamilton
Journal:  Clin Gastroenterol Hepatol       Date:  2011-08-24       Impact factor: 11.382

Review 7.  Gastroparesis.

Authors:  Michael Camilleri; Victor Chedid; Alexander C Ford; Ken Haruma; Michael Horowitz; Karen L Jones; Phillip A Low; Seon-Young Park; Henry P Parkman; Vincenzo Stanghellini
Journal:  Nat Rev Dis Primers       Date:  2018-11-01       Impact factor: 52.329

8.  Factors that contribute to the impairment of quality of life in gastroparesis.

Authors:  Henry P Parkman; Laura A Wilson; Katherine P Yates; Kenneth L Koch; Thomas L Abell; Richard W McCallum; Irene Sarosiek; Braden Kuo; Zubair Malik; Ron Schey; Robert J Shulman; Madhusudan Grover; Gianrico Farrugia; Laura Miriel; James Tonascia; Frank Hamilton; Pankaj J Pasricha
Journal:  Neurogastroenterol Motil       Date:  2021-01-25       Impact factor: 3.598

9.  Evaluation of the pharmacokinetics of trazpiroben (TAK-906) in the presence and absence of the proton pump inhibitor esomeprazole.

Authors:  Jatinder Kaur Mukker; George Dukes; Lisi Wang; Susanna Huh; Polyna Khudyakov; Mitsuhiro Nishihara; Chunlin Chen
Journal:  Clin Transl Sci       Date:  2022-02-26       Impact factor: 4.438

10.  United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

Authors:  Jolien Schol; Lucas Wauters; Ram Dickman; Vasile Drug; Agata Mulak; Jordi Serra; Paul Enck; Jan Tack
Journal:  United European Gastroenterol J       Date:  2021-04       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.